Sabrina Paganoni, MD, PhD

Articles

AMX0035’s Potential and Mechanism in ALS: Sabrina Paganoni, MD, PhD

September 28, 2021

With AMX0035 expected to be submitted to the FDA for review in the coming months, the investigator at the Healey & AMG Center for ALS at Massachusetts General Hospital chimed in to share her thoughts on its potential. [WATCH TIME: 3 minutes]

Sabrina Paganoni, MD, PhD: AMX0035 and the Future of ALS Care

August 20, 2020

The co-director of the Neurological Clinical Research Institute at Massachusetts General Hospital offered her perspective on the expected developments for ALS care in next few years, and where AMX0035 might fit in that landscape.